Lipid-mediated protein delivery of suicide nucleoside kinases

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Therapy

Background:

• Nucleoside kinases are explored as suicide genes for combined gene/chemotherapy in malignant tumors.
• Conventional suicide gene therapy involves delivering genetic material, which can be complex.

Purpose of the Study:

• To investigate a novel strategy of directly delivering nucleoside kinase proteins into cells without genetic material.
• To assess the efficacy of protein-lipid complexes for delivering functional nucleoside kinases into cancer cells.

Main Methods:

• Formed protein-lipid complexes using a lipopolyamine and dioleoyl phosphatidylethanolamine (BioPorter).
• Complexes contained recombinant herpes simplex virus type-1 thymidine kinase or Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
• Delivered complexes to human osteosarcoma and Chinese hamster ovary cell lines.

Main Results:

• Protein-lipid complexes were imported into cells via endocytosis, delivering enzymes to cytosol and nucleus.
• Delivered nucleoside kinases retained enzymatic activity.
• Cells treated with enzyme-lipid complexes showed increased sensitivity to nucleoside analogues (ganciclovir, BrdU, Ara-T).

Conclusions:

• Direct protein delivery of nucleoside kinases is a viable strategy for enhancing cancer cell sensitivity to chemotherapy.
• This method offers a potential alternative to traditional suicide gene therapy.
• Protein-lipid complexes effectively deliver functional enzymes for therapeutic applications.